Scale to stratify magnitude of clinical benefit of anticancer medicines

ESMO, the European Society for Medical Oncology, has announced the publication of the ESMO Magnitude of Clinical Benefit Scale, a tool to assist oncology clinicians in evaluating the most effective anti-cancer medicines for their patients. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail